Raymond James & Associates Johnson & Johnson Call Options Transaction History

Raymond James & Associates

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 08, 2023	BUY	$160.2 - $179.79 $1.79 Million - $2.01 Million	11,200 Added 23.14%	59,600 $10.5 Million
Q3 2022 Oct 25, 2022	SELL	$161.33 - $179.52 $64,532 - $71,808	-400 Reduced 0.82%	48,400 $43,000
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $2.41 Million - $2.66 Million	-14,300 Reduced 22.66%	48,800 $122,000
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $347,907 - $395,098	-2,200 Reduced 3.37%	63,100 $198,000
Q4 2021 Feb 08, 2022	SELL	$155.93 - $173.01 $3.12 Million - $3.46 Million	-20,000 Reduced 23.45%	65,300 $70,000
Q3 2021 Nov 02, 2021	BUY	$161.5 - $179.47 $6.02 Million - $6.69 Million	37,300 Added 77.71%	85,300 $51,000
Q2 2021 Aug 11, 2021	BUY	$159.48 - $171.07 $2.58 Million - $2.77 Million	16,200 Added 50.94%	48,000 $24,000
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $704,122 - $784,208	-4,600 Reduced 12.64%	31,800 $5,000
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $4.99 Million - $5.73 Million	36,400 New	36,400 $104,000

4,271

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.